Skip to content

Medical-device intelligence

NBT: Antibodies, Saccharomyces Cerevisiae (S.Cerevisiae)

FDA product code NBT: Antibodies, Saccharomyces Cerevisiae (S.Cerevisiae). View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
NBT
FDA device name
Antibodies, Saccharomyces Cerevisiae (S.Cerevisiae)
Device class
2
Regulation number
866.5785
Medical specialty
Immunology
Review panel
IM

The source does not provide a definition for this entry. Consult the FDA classification and regulation reference for further detail.

Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

7 clearance records and 0 recall records in the covered releases, across 6 source company names and 1 product codes. Dated history runs from May 21, 2001 to Nov 7, 2007.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
NBT · Antibodies, Saccharomyces Cerevisiae (S.Cerevisiae)70

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

7 matching records
Device / recordCompany in FDA recordSourceSource date
ASCA-CHEKK071711 · NBTTechlab Inc., Corporate Research Center510(k)Nov 7, 2007FDA decision date
TECHLAB ASCA-CHEKK051927 · NBTTechlab, Inc.510(k)Apr 6, 2006FDA decision date
AESKULISA ASCA AK051492 · NBTAesku, Inc.510(k)Nov 14, 2005FDA decision date
BINDAZYME HUMAN ASCA IGG AND IGA EIA DIAGNOSTIC TEST KITK042579 · NBTThe Binding Site510(k)Jul 28, 2005FDA decision date
IMMULISA ANTI-SACCHAROMYCES CEREVISIAE ANTIBODY (ASCA) (IGG)K032850 · NBTImmco Diagnostics, Inc.510(k)Mar 18, 2004FDA decision date
IMMULISA ANTI-SACCHAROMYCES CEREVISIAE ANTIBODY (ASCA) (IGA)K032860 · NBTImmco Diagnostics, Inc.510(k)Mar 18, 2004FDA decision date
QUANTA LITE ASCA (S. CEREVISIAE) IGA ELISAK000733 · NBTInova Diagnostics, Inc.510(k)May 21, 2001FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗